Agilent Technologies, Inc.

NYSE:A

Medical - Diagnostics & Research

Healthcare
$177.33 +2.44%

+$3.04 today

Market cap
$50.00B
Beta
1.26
P/E (TTM)
25.5
EPS (TTM)
$5.00
Dividend yield
0.59%
52W Low $108.35High $160.27

Volume 2.48M

Average 2.24M

A Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Agilent Technologies, Inc.NYSE: A

Net Receivables · Q3 FY2026 · quarter ended Jul 2026

Net receivables rises 6.9% from a year ago

Net receivables stood at $1.48B at the end of Q3 FY2026, up 6.9% from a year earlier and down 1.3% from the prior quarter. Over 3 fiscal years it compounded at +1.9% a year.

Context

  • Net receivables amounted to 10.6% of total assets at the end of Q3 FY2026, down 0.7 pp from a year earlier.
  • Net receivables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +6.9% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJul 2026
$1.48B-1.3% QoQ
Last fiscal yearOct 2025
$1.49B+12.3% YoY
Year agoJul 2025
$1.38B+6.9% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.9%——
1 year+12.3%——
3-year CAGR+1.9%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
1.49B USD
Year-over-year change
+12.3%
4-year CAGR
+6.1%

Net Receivables vs competitors

How A compares with its peers on the latest reported figures

  • A's Jul 2026 net receivables of $1.48B is the 4th highest of the 9 companies compared; the peer median is $803.44M.
  • Its year-over-year change of +6.9% is the 6th highest of 9, against a peer median of +7.3%.
  • Net receivables amounts to 10.6% of total assets for A, versus a peer median of 7.4%.
A Competitors Peer median
Net Receivables for A and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
TMOThermo Fisher Scientific Inc.Sep 2026$9.63B -8.6%+3.9%8.4%
DHRDanaher CorporationSep 2026$5.13B +36.5%-8.2%5.5%
WATWaters CorporationJul 2026$1.99B +172.2%+4.7%8.0%
AAgilent Technologies, Inc.Jul 2026$1.48B +6.9%+1.9%10.6%
BRKRBruker CorporationJun 2026$875.4M +18.5%+7.3%14.5%
MTDMettler-Toledo International Inc.Jun 2026$731.48M +7.3%+3.1%19.9%
RVTYRevvity, Inc.Jul 2026$709.18M +7.3%+6.7%5.9%
BIOBio-Rad Laboratories, Inc.Jun 2026$441.8M -6.0%-1.5%4.3%
QGENQiagen N.V.Jun 2026$399.05M +3.4%-2.5%6.8%
Peer median (excluding A) $803.44M+7.3%+3.5%7.4%

Competitors are the stored peer set for A. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Oct 2021
FY2022
Oct 2022
FY2023
Oct 2023
FY2024
Oct 2024
FY2025
Oct 2025
Cash & Equivalents1.48B1.05B1.59B1.33B1.79B
Short-term Investments91M0000
Net Receivables1.17B1.41B1.29B1.32B1.49B
Inventory830M1.04B1.03B991M1.03B
Other Current Assets222M282M274M315M293M
Total Current Assets3.8B3.78B4.19B3.96B4.59B
Property, Plant & Equipment (Net)945M1.1B1.42B1.96B2.02B
Goodwill3.98B3.95B3.96B4.47B4.47B
Intangible Assets981M821M475M547M445M
Long-term Investments185M195M164M175M133M
Tax Assets000436M0
Other Non-current Assets820M686M554M297M1.06B
Total Non-current Assets6.91B6.75B6.58B7.89B8.13B
Total Assets10.71B10.53B10.76B11.85B12.73B
Account Payables446M580M418M540M570M
Short-term Debt036M045M304M
Tax Payables0073M00
Deferred Revenue441M461M505M544M624M
Other Current Liabilities493M455M371M326M443M
Total Current Liabilities1.71B1.86B1.6B1.9B2.35B
Long-term Debt2.73B2.73B2.74B3.35B3.05B
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities879M633M580M566M589M
Total Non-current Liabilities3.61B3.37B3.32B4.05B3.64B
Total Liabilities5.32B5.23B4.92B5.95B5.99B
Common Stock3M3M3M3M3M
Retained Earnings348M324M782M750M1.39B
Accumulated OCI(282M)(347M)(327M)(305M)(226M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity5.39B5.31B5.85B5.9B6.74B
Total Debt2.73B2.77B2.74B3.57B3.35B
Net Debt1.25B1.72B1.15B2.25B1.57B

Agilent Technologies, Inc.

NYSE:A

Intrinsic Alpha fair value

Locked

Current Price

$177.33

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.